| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
|
04.03.2025 13:43:59
|
EQS-Adhoc: Ad-hoc: CompuGroup Medical SE & Co. KGaA intends to reduce the annual dividend for the financial year 2024 to the legal minimum
|
EQS-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Dividend The general partner and the supervisory board of CompuGroup Medical SE & Co. KGaA (the „Company“) (ISIN: DE000A288904 | WKN: A28890) intend to propose to the annual general meeting that only the legally required minimum shall be paid out as dividend for the financial year 2024. This would result in a distribution of EUR 0.05 per dividend bearing share (previous year: EUR 1.00), assuming an unchanged amount of treasury shares. The proposal is made against the backdrop of the Company’s long-term innovation and growth strategy, including investments in infrastructure and resources for greater proximity to customers as well as AI-based processes and products. It further considers, based on the prepared consolidated financial statements, the development of revenue and profitability in the financial year 2024 in line with the adjusted full-year forecast. According to the prepared consolidated financial statements, the Company generated revenues of approx. EUR 1.154 billion in the financial year 2024 (previous year: approx. EUR 1.188 billion). The organic revenue decreased by around two per cent year-on-year. Adjusted EBITDA decreased by around 15 per cent to approx. EUR 224.6 million (previous year: approx. EUR 264.8 million). The adjusted earnings per share amounted to approx. EUR 1.27 (previous year: approx. EUR 2.06). A dividend payment based on the final dividend proposal of the general partner and the supervisory board for the financial year 2024 is subject to the approval by the annual general meeting, which is expected to be held in August 2025, as well as further legal requirements. CompuGroup Medical SE & Co. KGaA will publish the full annual report for the financial year 2024 as planned on March 6, 2025. “Adjusted EBITDA” and “adjusted earnings per share” are defined in the annual report for the financial year 2023 on p. 45 et seq. End of Inside Information
04-March-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | CompuGroup Medical SE & Co. KGaA |
| Maria Trost 21 | |
| 56070 Koblenz | |
| Germany | |
| Phone: | +49 (0)160 3630362 |
| Fax: | +49 (0)261 8000 3200 |
| E-mail: | investor@cgm.com |
| Internet: | www.cgm.com |
| ISIN: | DE000A288904 |
| WKN: | A28890 |
| Indices: | SDAX, TecDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2095063 |
| End of Announcement | EQS News Service |
|
|
2095063 04-March-2025 CET/CEST
Nachrichten zu CompuGroup Medical SE & Co. KGaA
|
10:02 |
TecDAX-Papier CompuGroup Medical SE-Aktie: So viel Verlust hätte ein CompuGroup Medical SE-Investment von vor 5 Jahren eingefahren (finanzen.ch) | |
|
09:29 |
XETRA-Handel: Anleger lassen TecDAX zum Start steigen (finanzen.ch) | |
|
11.04.25 |
XETRA-Handel: TecDAX-Anleger greifen zum Start zu (finanzen.ch) | |
|
10.04.25 |
TecDAX aktuell: TecDAX verbucht letztendlich deutliche Zuschläge (finanzen.ch) | |
|
10.04.25 |
TecDAX aktuell: Das macht der TecDAX am Nachmittag (finanzen.ch) | |
|
10.04.25 |
TecDAX-Handel aktuell: TecDAX springt mittags kräftig an (finanzen.ch) | |
|
10.04.25 |
Freundlicher Handel: So bewegt sich der SDAX mittags (finanzen.ch) | |
|
10.04.25 |
Gewinne in Frankfurt: TecDAX zeigt sich zum Start des Donnerstagshandels mit sattem Kursplus (finanzen.ch) |
Analysen zu CompuGroup Medical SE & Co. KGaA
| 11.04.25 | CompuGroup Medical Buy | Baader Bank | |
| 18.03.25 | CompuGroup Medical Buy | Baader Bank | |
| 06.03.25 | CompuGroup Medical Buy | Baader Bank | |
| 24.02.25 | CompuGroup Medical Buy | Baader Bank | |
| 03.02.25 | CompuGroup Medical Buy | Baader Bank |
Im BX Morningcall werden folgende Aktien analysiert und erklärt:
✅ Trane Technologies
✅ Deutsche Boerse
✅ Euronext N.V
Pünktlich zum Börsenstart diskutieren Investment-Stratege François Bloch und Börsen-Experte David Kunz oder Olivia Hähnel über ausgewählte Top-Aktienwerte aus dem BX Musterportfolio.
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Aktien in diesem Artikel
| CompuGroup Medical SE & Co. KGaA | 21.34 | 7.10% |
|
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
SMI und DAX in Grün -- Börsen in Asien letztlich mit GewinnenDer heimische und deutsche Aktienmarkt notieren am Montag klar höher. Asiens Börsen verbuchten zum Wochenauftakt kräftige Zuschläge.
finanzen.net News
| Datum | Titel |
|---|---|
|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |